Stock screenerAll disclosures →
EDGAR →
MBIO
Conviction 20HealthcareScan · Mon, Aug 10, 2026MBIO$0.6000-0.12%
ResistanceSupportVol 14Vol MA14 49.03K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price0.6000
Change-0.12%
Gap-0.12%
Rel volume6.94×
Avg volume41.96K
Avg $ vol25.3K
SMA 200.6018
SMA 500.6665
SMA 2000.8971
Price vs 50-9.98%
Price vs 200-33.12%
MA stackbearish
50/200 cross—
Supertrenddown · 0.6982
RSI (14)46
MACD hist0.00
MACD crossbull · 3d
Stoch %K / %D56 / 50
ADX (14)13
+DI / −DI17 / 22
RSI divergence—
MACD divergence—
ATR %+8.79%
ADR %8.06%
52w high1.87
52w low0.5600
From 52w high-67.91%
Above 52w low+7.14%
New 52w highNo
SqueezeOn · 3d
Bollinger width20.00%
%B0.48
Donchian pos46.33%
Donchian high0.6870
Donchian low0.5249
AVWAP (52w high)0.9776
vs AVWAP high-38.63%
AVWAP (52w low)0.5939
vs AVWAP low+1.02%
OBV trendDown
Chaikin MF (20)-0.33
Today vs 20d6.94×
Avg vol (14d)49.03K
Avg vol (20d)41.96K
Avg $ vol (20d)25.3K
Market cap14.99M
RS 3m (vs SPY)-23.07%
RS 6m (vs SPY)-29.77%
RS line new highNo
Trend template0/8
Technical rank14.3
1 week+4.06%
1 month-14.72%
3 months-13.79%
6 months-23.78%
1 year-60.53%
YTD-43.93%
P/E-7.80
P/B1.99
P/S—
P/FCF-2.85
EPS-0.3900
Div yield—
ROE-25.46%
ROA-12.30%
Debt/Eq0.00
Current2.22
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth87.80%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value-164.23K
Revenue—
Net income-1.07M
Gross profit—
Free cash flow-5.26M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out6.73M
Employees4
ListedTue, Aug 22, 2017
Free float6.19M
Float %92.0%
Short interest60.87K
Days to cover1.4d
Short volume6.2%
Squeeze score24 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction20 / 100
Pattern quality—
Tech rank14.3 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance0.7649
Support0.5276
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in MBIO
No recent disclosed trades by Congress in MBIO. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in MBIO · 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Litchman Manuel MD President, CEO and Interim CFO · COMMON STOCK · 2026-04-24 | Tax | 19 | $14 | 2026-04-24 | 2026-04-27 |
SEC filings
EDGAR filings in MBIO · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.